|

AVZO-021 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 1/2: 2

Top Sponsors

  • Avenzo Therapeutics, Inc.2

Indications

  • HR+, HER2-, Advanced Breast Cancer2
  • HR+/HER2- Breast Cancer2
  • Breast Cancer2
  • Cancer2
  • CCNE1 Amplification1

Los Angeles, California1 trial

ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors

Avenzo Therapeutics Recruiting Site

Phase 1/2

New Haven, Connecticut1 trial

Study of AVZO-021 in Patients With Advanced Solid Tumors

Yale Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.